PFIZER
|
The Current P/B Ratio of PFIZER is 5.35.
| Share Price | ₹4,937.8 | Feb 20,2026 |
| Market Cap | ₹22,565.5 Cr | |
| Book Value | ₹4,217.4 Cr | Mar2025 - Standalone Results |
| Price/Book | 5.35x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of PFIZER
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹22,565.5 Cr] as on Feb 20,2026
(/) Book Value [ ₹4,217.4 Cr] based on Mar2025 - Standalone Results
(=) P/B Ratio [ 5.35x ]
Thus, for PFIZER , the investors are currently willing to pay '5.35 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of PFIZER !
The chart below summarizes the trend in P/B Ratio of PFIZER over the last five years.
Historical PB (Price/Book ) ratio chart of PFIZER
PB Ratio Performance Analysis for PFIZER
- PFIZER 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 6.04x.
- PFIZER 's operated at median p/b ratio of 5.34x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PFIZER 's p/b ratio peaked in Mar2021 at 8.64x.
- PFIZER 's p/b ratio hit its five-year low in Mar2025 of 4.34x.
How does PFIZER 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| PFIZER | 4,217.41 | 5.35 | 22,565.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 5.73 | 413,753.0 |
| DIVIS LABORATORIES LTD | 14,969.00 | 11.16 | 167,032.0 |
| CIPLA LTD | 31,079.30 | 3.49 | 108,360.0 |
| TORRENT PHARMACEUTICALS LTD | 7,590.69 | 18.89 | 143,426.0 |
| DR REDDYS LABORATORIES LTD | 33,404.90 | 3.20 | 106,859.0 |
| MANKIND PHARMA LTD | 14,288.70 | 5.86 | 83,688.0 |
| ZYDUS LIFESCIENCES LTD | 23,953.10 | 3.78 | 90,661.7 |
| LUPIN LTD | 17,119.50 | 5.93 | 101,450.0 |
| AUROBINDO PHARMA LTD | 32,653.30 | 2.06 | 67,358.5 |
| ABBOTT INDIA LTD | 4,204.27 | 13.27 | 55,807.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs PFIZER 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.06x |
| Max industry PB | 18.89x |
| Median industry PB | 5.73x |
| Average industry PB | 7.16x |
You may also like the below Video Courses